证券记录 · 已归档季度
RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
15被追踪持有人
0Δ持有人
38.20M持有股份
$124.54M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +10.8% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Millennium Management ✦ | 3.57M | +52.0% | $11.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 2.19M | +120.6% | $7.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 2.19M | +120.6% | $7.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Geode Capital Management ✦ (被动) | 1.91M | -5.7% | $6.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Geode Capital Management ✦ (被动) | 1.91M | -5.7% | $6.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 42 | State Street Global Advisors ✦ (被动) | 1.75M | -10.2% | $5.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 1.67M | +970.8% | $5.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | Two Sigma Investments ✦ | 1.61M | -6.7% | $5.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 1.27M | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 1.27M | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 1.06M | -3.5% | $3.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 1.06M | -3.5% | $3.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 311.70K | +17.2% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 311.70K | +17.2% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 56 | Renaissance Technologies ✦ | 137.18K | -70.3% | $447,197 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 195 持有人, 96.37M 股份, $341.40M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 18
Shah Gaurav
Officer · 2.29K 股 · $7,753
Aug 18
Wilson Martin
Officer · 631 股 · $2,133
Aug 11
Chaudhuri Sarbani
Officer · 4.70K 股 · $16,449
Aug 11
Stevens Christopher James
Officer · 36.66K 股 · $128,266
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 31
SC 13G — VANGUARD PORTFOLIO MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据